We are live on ! Find out more
FBIO icon

Fortress Biotech
FBIO

77 hedge funds and large institutions have $117M invested in Fortress Biotech in 2020 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 30 increasing their positions, 14 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

114% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 14

92% more capital invested

Capital invested by funds: $60.6M → $117M (+$56M)

40% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 10

5% more funds holding

Funds holding: 73 → 77 (+4)

0.51% more ownership

Funds ownership: 1.83% → 2.33% (+0.51%)

Holders
77
Holders Change
+4
Holders Change %
+5.48%
% of All Funds
1.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
30
Reduced
14
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
NCM
Nantahala Capital Management
Connecticut
+$12.9M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$3.47M
3
Morgan Stanley
Morgan Stanley
New York
+$3.06M
4
BlackRock
BlackRock
New York
+$1.93M
5
Two Sigma Investments
Two Sigma Investments
New York
+$1.79M

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$1.95M
2
FIA
FNY Investment Advisers
New York
-$469K
3
Jane Street
Jane Street
New York
-$326K
4
Bank of America
Bank of America
North Carolina
-$86K
5
SG Americas Securities
SG Americas Securities
New York
-$85K
Name Holding Trade Value Shares
Change 		Change in
Stake
Osaic Holdings
51
Osaic Holdings
Arizona
$96K +$40.7K +800 +101%
CS
52
Candriam SCA
Luxembourg
$91K – – –
State Board of Administration of Florida Retirement System
53
State Board of Administration of Florida Retirement System
Florida
$91K – – –
Bank of America
54
Bank of America
North Carolina
$85K -$86K -1,688 -55%
MLICM
55
Metropolitan Life Insurance Company (MetLife)
New York
$84.8K +$71.3K +1,399 New
DY
56
Dowling & Yahnke
California
$81K – – –
TI
57
Telemetry Investments
New York
$74K -$6.77K -133 -10%
BNP Paribas Financial Markets
58
BNP Paribas Financial Markets
France
$60.5K +$43.4K +852 +584%
DT
59
Diversified Trust
Tennessee
$53K +$44.2K +867 New
GIA
60
Gladstone Institutional Advisory
Florida
$46K +$3.41K +67 +10%
Victory Capital Management
61
Victory Capital Management
Texas
$44K +$1.22K +24 +3%
Federated Hermes
62
Federated Hermes
Pennsylvania
$41K +$34.8K +684 New
Legal & General Group
63
Legal & General Group
United Kingdom
$30K -$7.59K -149 -23%
EWM
64
Edge Wealth Management
New York
$24K – – –
Citigroup
65
Citigroup
New York
$22K -$24.2K -475 -56%
AIP
66
Ameritas Investment Partners
Nebraska
$21K – – –
CG
67
Cutler Group
California
$16K – – –
Bank of Montreal
68
Bank of Montreal
Ontario, Canada
$12K -$6.16K -121 -38%
Skandinaviska Enskilda Banken (SEB)
69
Skandinaviska Enskilda Banken (SEB)
Sweden
$12K – – –
DWA
70
Dorsey Wright & Associates
California
$9K +$7.23K +142 New
HFM
71
Hartford Financial Management
Connecticut
$8K – – –
OSAM
72
O'Shaughnessy Asset Management
Connecticut
$8K – – –
UBS Group
73
UBS Group
Switzerland
$6K -$69.4K -1,362 -93%
Millennium Management
74
Millennium Management
New York
$2.75K +$835K +16,401 +57%
Northwestern Mutual Wealth Management
75
Northwestern Mutual Wealth Management
Wisconsin
$2K – – –
1 2
3
4

FBIO Hedge Fund Activity: Q3 2020 in Review

77 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Fortress Biotech (FBIO) for Q3 2020, worth a combined $117M — up 92% from $60.6M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new FBIO positions and 10 closed out — a net gain of 4 holders — while 30 added to existing stakes and 14 trimmed.

The largest buyer was Nantahala Capital Management, adding an estimated $12.9M. The largest seller was Renaissance Technologies, cutting an estimated $1.95M.

  • 77 institutional investors held Fortress Biotech (FBIO) as of Q3 2020, up from 73 in Q2 2020.
  • Funds reported $117M of Fortress Biotech stock for Q3 2020, up 92% quarter-over-quarter.
  • 14 funds opened new Fortress Biotech positions in Q3 2020 and 10 closed out, a net change of +4 holders.
  • The largest Fortress Biotech buyer in Q3 2020 was Nantahala Capital Management, an estimated $12.9M added.
  • The largest Fortress Biotech seller in Q3 2020 was Renaissance Technologies, an estimated $1.95M sold.

Based on aggregated 13F filings for Q3 2020.